Type
1.
Ahorlu C, Koka E, Adu-Amankwah S, Otchere J, Souza DK. Community perspectives on persistent transmission of lymphatic filariasis in three hotspot districts in Ghana after 15 rounds of mass drug administration: a qualitative assessment. BMC public health [Internet]. 2018;18(1):238. Available from: https://tinyurl.com/yap9sdld
Type
1.
Khieu V, Or V, Tep C, Odermatt P, Tsuyuoka R, Char MC, et al. How elimination of lymphatic filariasis as a public health problem in the Kingdom of Cambodia was achieved. Infectious diseases of poverty [Internet]. 2018;7(1):15. Available from: https://tinyurl.com/yc7vps2e
Type
1.
Krentel A, Wellings K. The role of gender relations in uptake of mass drug administration for lymphatic filariasis in Alor District, Indonesia. Parasites & vectors [Internet]. 2018;11(1):179. Available from: https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-018-2689-8
Type
1.
Pronk M, Phillip M, Schaafsma A. Best practices in strengthening health systems for integrated care for people affected by leprosy and LF. 2018.
Type
1.
Obadiah ES, Sambo ED, Alhaji MA, Elisha AD, Santaya K, Greg A, et al. Rapid epidemiological assessment of lymphatic filariasis in northern Taraba Focus, Nigeria. International journal of infectious diseases and therapy [Internet]. 2018;3(1):6-12. Available from: http://article.ijidt.org/pdf/10.11648.j.ijidt.20180301.12.pdf
Type
Year of Publication
2007
Publication Language
eng
Citation Key
31507
Type
1.
Chandrasena N, Premaratna R, Gunaratna I, Silva N. Morbidity management and disability prevention for lymphatic filariasis in Sri Lanka: Current status and future prospects. PLoS neglected tropical diseases [Internet]. 2018;12(5):e0006472. Available from: http://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0006472&type=printable
Type
1.
Kebede B, Martindale S, Mengistu B, Kebede B, Mengiste A, H/Kiros F, et al. Integrated morbidity mapping of lymphatic filariasis and podoconiosis cases in 20 co-endemic districts of Ethiopia. PLoS neglected tropical diseases [Internet]. 2018;:28. Available from: http://sro.sussex.ac.uk/75756/2/Revised%20Article%20with%20Changes%20Highlighted%20v3.pdf
Type
1.
Budge P, Herbert C, Andersen B, Weil G. Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature. PLoS neglected tropical diseases [Internet]. 2018;12(5):e0006454. Available from: http://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0006454&type=printable
Type
1.
Sime H, Gass K, Mekasha S, Assefa A, Woyessa A, Shafi O, et al. Results of a confirmatory mapping tool for Lymphatic filariasis endemicity classification in areas where transmission was uncertain in Ethiopia. PLoS neglected tropical diseases [Internet]. 2018;12(3):e0006325. Available from: http://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0006325&type=printable